PTC THERAPEUTICS, INC. — Director's Dealing 2021

Jan 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-01-08

Reporting Person: Almstead Neil Gregory (Chief Technical Ops Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-08	Common Stock	M	1300	$27.05	Acquired	3688	Indirect
2021-01-08	Common Stock	S	1300	$69.00	Disposed	2388	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-08	Stock Option (Right to Buy)	$27.05	M	1300	Disposed	2024-01-27	Common Stock (1300)	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$490.8	2021-04-27	Common Stock (7)	7	Indirect
Stock Option (Right to Buy)	$218.4	2022-01-10	Common Stock (7)	7	Indirect
Stock Option (Right to Buy)	$51	2025-01-01	Common Stock (2060)	2060	Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the spouse of the Reporting Person on November 10, 2020.

F2: Currently exercisable.